IPCI : Summary for Intellipharmaceutics Internatio - Yahoo Finance

U.S. Markets closed

IntelliPharmaCeutics International Inc. (IPCI)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.80+0.09 (+3.32%)
At close: 4:00 PM EST
People also watch:
IDRACPRXBLRXOPXACLSN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.71
Open2.73
Bid2.67 x 700
Ask3.50 x 900
Day's Range2.71 - 2.89
52 Week Range1.41 - 3.35
Volume144,567
Avg. Volume503,052
Market Cap83.23M
Beta0.85
PE Ratio (TTM)-7.63
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire5 days ago

    Intellipharmaceutics to Present at the LD Micro Main Event

    TORONTO, Nov. 29, 2016-- Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release ...

  • IntelliPharmaCeutics Intl Inc (USA) (IPCI) Needs A Partner
    Insider Monkey6 days ago

    IntelliPharmaCeutics Intl Inc (USA) (IPCI) Needs A Partner

    IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) just announced the submission of its New Drug Application (NDA) for Rexista, it’s bioequivalent OxyContin product. The application comes a little later than first expected, but it’s now in the bag, and the result could be a game changer for the company. It’s targeting an abuse deterrent approval, and if […]

  • Intellipharmaceutics Submits NDA for Pain Treatment Rexista
    Zacks6 days ago

    Intellipharmaceutics Submits NDA for Pain Treatment Rexista

    Intellipharmaceutics International Inc. (IPCI) announced that it has filed a new drug application (NDA) with the FDA for Rexista.